Visceral fat and gut inflammation

Nutrition

Volumn 28, Issue 2, 2012, Pages 113-117

  Drouet, Maryline ^a,b   Dubuquoy, Laurent ^a,b   Desreumaux, Pierre ^a,b,c   Bertin, Benjamin ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Adipokines; Adipose tissue; Creeping fat; Crohn's disease; Inflammation; Mesenteric fat; Visceral fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; CHEMERIN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 6; LEPTIN; MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; PLASMA PROTEIN; RESISTIN; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOSE TISSUE; CREEPING FAT; CROHN DISEASE; DISEASE MODEL; ENTERITIS; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; INTESTINE FLORA; INTRAABDOMINAL FAT; MESENTERIC ADIPOSE TISSUE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; WHITE ADIPOSE TISSUE;

CHORISTOMA; CROHN DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; INTRA-ABDOMINAL FAT; MESENTERY;

ANIMALIA;

EID: 84855238311     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.09.009     Document Type: Review

References (54)

1. White R.T., Damm D., Hancock N., Rosen B.S., Lowell B.B., Usher P., et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 1992, 267:9210-9213.
2. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
3. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
4. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
5. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010, 1212:E1-E19.
6. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
7. Cousin B., Munoz O., Andre M., Fontanilles A.M., Dani C., Cousin J.L., et al. A role for preadipocytes as macrophage-like cells. FASEB J 1999, 13:305-312.
8. Charriere G., Cousin B., Arnaud E., Andre M., Bacou F., Penicaud L., et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003, 278:9850-9855.
9. Schaffler A., Scholmerich J., Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 2007, 28:393-399.
10. Kopp A., Buechler C., Bala M., Neumeier M., Scholmerich J., Schaffler A. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. Endocrinology 2010, 151:1097-1108.
11. Stroh T., Batra A., Glauben R., Fedke I., Erben U., Kroesen A., et al. Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes. J Immunol 2008, 181:3620-3627.
12. Crohn B.B., Ginzburg L., Oppenheimer G.D. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer. JAMA 1984, 251:73-79.
13. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
14. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078.
15. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 2007, 56:577-583.
16. Sheehan A.L., Warren B.F., Gear M.W., Shepherd N.A. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 1992, 79:955-958.
17. Borley N.R., Mortensen N.J., Jewell D.P., Warren B.F. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol 2000, 190:196-202.
18. Yamamoto K., Kiyohara T., Murayama Y., Kihara S., Okamoto Y., Funahashi T., et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005, 54:789-796.
19. Desreumaux P., Ernst O., Geboes K., Gambiez L., Berrebi D., Muller-Alouf H., et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999, 117:73-81.
20. Paul G., Schaffler A., Neumeier M., Furst A., Bataillle F., Buechler C., et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006, 12:471-477.
21. Frederich R.C., Lollmann B., Hamann A., Napolitano-Rosen A., Kahn B.B., Lowell B.B., et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995, 96:1658-1663.
22. La Cava A., Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004, 4:371-379.
23. Batra A., Okur B., Glauben R., Erben U., Ihbe J., Stroh T., et al. Leptin: a critical regulator of CD4+ T-cell polarization invitro and invivo. Endocrinology 2010, 151:56-62.
24. Siegmund B., Lehr H.A., Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002, 122:2011-2025.
25. Ohashi K., Parker J.L., Ouchi N., Higuchi A., Vita J.A., Gokce N., et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010, 285:6153-6160.
26. Nishihara T., Matsuda M., Araki H., Oshima K., Kihara S., Funahashi T., et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 2006, 131:853-861.
27. Fayad R., Pini M., Sennello J.A., Cabay R.J., Chan L., Xu A., et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007, 132:601-614.
28. Karmiris K., Koutroubakis I.E., Xidakis C., Polychronaki M., Voudouri T., Kouroumalis E.A. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:100-105.
29. Valentini L., Wirth E.K., Schweizer U., Hengstermann S., Schaper L., Koernicke T., et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009, 25:172-181.
30. Ogunwobi O.O., Beales I.L. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006, 134:105-113.
31. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. JAllergy Clin Immunol 2008, 121:326-330.
32. Schaffler A., Scholmerich J. The role of adiponectin in inflammatory gastrointestinal diseases. Gut 2009, 58:317-322.
33. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
34. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines invitro. Biochem Biophys Res Commun 2003, 309:286-290.
35. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
36. Konrad A., Lehrke M., Schachinger V., Seibold F., Stark R., Ochsenkuhn T., et al. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol 2007, 19:1070-1074.
37. Daquinag A.C., Zhang Y., Amaya-Manzanares F., Simmons P.J., Kolonin M.G. An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell 2011, 9:74-86.
38. Ernst M.C., Sinal C.J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010, 21:660-667.
39. Cash J.L., Hart R., Russ A., Dixon J.P., Colledge W.H., Doran J., et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. JExp Med 2008, 205:767-775.
40. Yoshimura T., Oppenheim J.J. Chemerin reveals its chimeric nature. J Exp Med 2008, 205:2187-2190.
41. Weigert J., Obermeier F., Neumeier M., Wanninger J., Filarsky M., Bauer S., et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010, 16:630-637.
42. Ouchi N., Higuchi A., Ohashi K., Oshima Y., Gokce N., Shibata R., et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010, 329:454-457.
43. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007, 178:1748-1758.
44. Schaffler A., Neumeier M., Herfarth H., Furst A., Scholmerich J., Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005, 1732:96-102.
45. Yamawaki H., Kuramoto J., Kameshima S., Usui T., Okada M., Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011, 408:339-343.
46. Han S., Wang G., Qiu S., de la Motte C., Wang H.Q., Gomez G., et al. Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regul Pept 2007, 142:131-137.
47. Karagiannides I., Kokkotou E., Tansky M., Tchkonia T., Giorgadze N., O'Brien M., et al. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci U S A 2006, 103:5207-5212.
48. Koon H.W., Kim Y.S., Xu H., Kumar A., Zhao D., Karagiannides I., et al. Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis. Proc Natl Acad Sci U S A 2009, 106:8766-8771.
49. Olivier I., Theodorou V., Valet P., Castan-Laurell I., Guillou H., Bertrand-Michel J., et al. Is Crohn's creeping fat an adipose tissue?. Inflamm Bowel Dis 2011, 17:747-757.
50. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, et al. Mesenteric fat as a source of C-reactive protein and a target for bacterial translocation in Crohn's disease. Gut 2011, epub ahead of print.
51. Bertin B., Desreumaux P., Dubuquoy L. Obesity, visceral fat and Crohn's disease. Curr Opin Clin Nutr Metab Care 2010, 13:574-580.
52. Behr M.A. The path to Crohn's disease: is mucosal pathology a secondary event? Inflamm Bowel Dis. 18 nov 2009, 16:896-902.
53. Hou J.K., Abraham B., El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011, 106:563-573.
54. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.